ZVSA Annual Total Long Term Liabilities
$844.90 K
-$9.48 M-91.82%
01 December 2023
Summary:
As of January 23, 2025, ZVSA annual total long term liabilities is $844.90 thousand, with the most recent change of -$9.48 million (-91.82%) on December 1, 2023. During the last 3 years, it has fallen by -$842.20 thousand (-49.92%). ZVSA annual total long term liabilities is now -91.82% below its all-time high of $10.32 million, reached on December 31, 2022.ZVSA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVSA Quarterly Long Term Liabilities
$854.60 K
$0.000.00%
01 September 2024
Summary:
As of January 23, 2025, ZVSA quarterly total long term liabilities is $854.60 thousand, unchanged on September 1, 2024. Over the past year, it has increased by +$9700.00 (+1.15%). ZVSA quarterly long term liabilities is now -91.72% below its all-time high of $10.32 million, reached on December 31, 2022.ZVSA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVSA Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -91.8% | +1.1% |
| 3 y3 years | -49.9% | +100.0% |
| 5 y5 years | -49.9% | +100.0% |
ZVSA Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.8% | -91.7% | ||
| 5 y | 5-year | -91.8% | -91.7% | ||
| alltime | all time | -91.8% | -91.7% |
ZyVersa Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $854.60 K(0.0%) |
| June 2024 | - | $854.60 K(+1.1%) |
| Mar 2024 | - | $844.90 K(0.0%) |
| Dec 2023 | $844.90 K | $844.90 K(-41.4%) |
| Sept 2023 | - | $1.44 M(-0.0%) |
| June 2023 | - | $1.44 M(-84.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $9.28 M(-10.1%) |
| Dec 2022 | $10.32 M(>+9900.0%) | $10.32 M(>+9900.0%) |
| Sept 2022 | - | $0.00(0.0%) |
| June 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(-100.0%) | - |
| Dec 2021 | - | $0.00 |
| Dec 2020 | $1.69 M | - |
FAQ
- What is ZyVersa Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual total long term liabilities year-on-year change?
- What is ZyVersa Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly long term liabilities year-on-year change?
What is ZyVersa Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ZVSA is $844.90 K
What is the all time high annual total long term liabilities for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual total long term liabilities is $10.32 M
What is ZyVersa Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ZVSA annual total long term liabilities has changed by -$9.48 M (-91.82%)
What is ZyVersa Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ZVSA is $854.60 K
What is the all time high quarterly long term liabilities for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly total long term liabilities is $10.32 M
What is ZyVersa Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ZVSA quarterly total long term liabilities has changed by +$9700.00 (+1.15%)